These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3508235)

  • 1. Brain monoamines after portacaval anastomosis.
    Mans AM; Hawkins RA
    Metab Brain Dis; 1986 Mar; 1(1):45-52. PubMed ID: 3508235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of portacaval anastomosis on the 5-hydroxytryptamine, histamine, and catecholamine neurotransmitter systems in rat brain.
    Lozeva V; MacDonald E; Belcheva A; Hippeläinen M; Kosunen H; Tuomisto L
    J Neurochem; 1998 Oct; 71(4):1450-6. PubMed ID: 9751177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmittor changes in the rat brain after portacaval anastomosis.
    Simert G; Mobin A; Rosengren E; Vang J
    Eur Surg Res; 1978; 10(2):73-85. PubMed ID: 26572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain monoamines and their metabolites after portacaval shunting.
    Mans AM; Consevage MW; DeJoseph MR; Hawkins RA
    Metab Brain Dis; 1987 Sep; 2(3):183-93. PubMed ID: 2463462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain monoamine metabolism and behavior in portacaval-shunted rats.
    Bengtsson F; Gage FH; Jeppsson B; Nobin A; Rosengren E
    Exp Neurol; 1985 Oct; 90(1):21-35. PubMed ID: 2412877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts.
    Fogel WA; Andrzejewski W; Sasiak K; Maslinski C
    Inflamm Res; 2000 Apr; 49 Suppl 1():S45-6. PubMed ID: 10864416
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.
    Wikell C; Apelqvist G; Hjorth S; Kullingsjö J; Bergqvist PB; Bengtsson F
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):327-36. PubMed ID: 12126872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
    Bergeron M; Reader TA; Layrargues GP; Butterworth RF
    Neurochem Res; 1989 Sep; 14(9):853-9. PubMed ID: 2480534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary amino acids on brain amino acids and transmitter amines in rats with a portacaval shunt.
    Kamata S; Okada A; Watanabe T; Kawashima Y; Wada H
    J Neurochem; 1980 Nov; 35(5):1190-9. PubMed ID: 6161235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portacaval shunt in the rat: selective alterations in behavior and brain serotonin.
    Bengtsson F; Nobin A; Falck B; Gage FH; Jeppsson B
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1611-6. PubMed ID: 2426719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of blood ingestion on brain serotonin synthesis in portacaval-shunted rats.
    Bartelmess P; Bengtsson F; Nobin A; Jeppsson B; Herlin P; Bugge M
    Res Exp Med (Berl); 1987; 187(5):353-8. PubMed ID: 2448852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat.
    Wasterlain CG; Lockwood AH; Conn M
    Neurology; 1978 Mar; 28(3):233-8. PubMed ID: 564477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts.
    Hawkins PA; DeJoseph MR; Viña JR; Hawkins RA
    J Appl Physiol (1985); 1996 Mar; 80(3):885-91. PubMed ID: 8964752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
    Bergqvist PB; Vogels BA; Bosman DK; Maas MA; Hjorth S; Chamuleau RA; Bengtsson F
    J Neurochem; 1995 Mar; 64(3):1238-44. PubMed ID: 7532208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
    Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
    J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of bromocriptine on brain levels of noradrenaline, dopamine and serotonin in experimental portosystemic encephalopathy].
    Arias J; Alsasua A; Estébanez E; López-Sánchez ML; Arias JI; García de Jalón PD; Durán Sacristán H
    Rev Clin Esp; 1983 Mar; 168(5):339-41. PubMed ID: 6867408
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis.
    Lozeva V; Montgomery JA; Tuomisto L; Rocheleau B; Pannunzio M; Huet PM; Butterworth RF
    J Hepatol; 2004 May; 40(5):742-8. PubMed ID: 15094220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional blood-brain barrier transport of glucose after portacaval anastomosis.
    Mans AM; Davis DW; Hawkins RA
    Metab Brain Dis; 1986 Jun; 1(2):119-28. PubMed ID: 3508237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the oral administration of branched chain amino acids on hepatic encephalopathy in the rat.
    Beaubernard C; Delorme ML; Opolon P; Boschat M; Morin J; Oryszcyn MP; Franco D
    Hepatology; 1984; 4(2):288-94. PubMed ID: 6200419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term portocaval shunt and changes in rat brain amine systems.
    Fogel WA; Andrzejewski W; Sasiak K
    Neurobiology (Bp); 1999; 7(4):413-20. PubMed ID: 10897801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.